Javelin Pharmaceuticals Inc (JAV)

[urche]

moving on

Well, I liked the story a few years ago and JAV seemed like a speculative , risky, but worthwhile stock to own. But, the story has changed and today I decided to sell. I still don't understand why the market doesn't value its pipeline higher. But, the Myriad deal seems to obscure rather than enhance the value to me. In fact, if anything Myriad seems like a short sell prospect to me.
So, thanks all, I wish you well. I am moving on.

Urche